Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Yingchi Technology develops advanced medical devices for precise diagnosis and treatment of brain and neurological diseases. Their flagship products are Transcranial Magnetic Stimulation (TMS) systems used in treating major depressive disorder and other neuropsychiatric conditions. The company’s Brain Ultimate TMS system has received regulatory clearances in multiple jurisdictions including FDA clearance for major depressive disorder as of September 2023. They have a strong R&D focus on neuroscience technologies with both clinical support and research business units.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Yingzhi Technology.